Platinum re-exposure as a non-small cell lung cancer (NSCLC) treatment strategy in the age of immunotherapy
Effective treatment strategies after immunotherapy are greatly needed in NSCLC. The time off platinum chemotherapy (platinum-free-interval) is one predictor used to select patients for platinum re-exposure in other malignancies, but is not known in NSCLC. We analyzed a retrospective cohort of 751 patients who underwent this approach and did not find that the platinum-free-interval predicted better outcomes after platinum re-exposure.
This article was first shared by INDoximity